News & Perspective

Jul 11, 2018

Jul 11, 2018

Stewardship / Resistance Scan for Jul 11, 2018

Fluoroquinolone safety update
Kids' fevers and antibiotics
Resistant Klebsiella in Europe
Ceftolozane-tazobactam against E coli

Jul 06, 2018

Jul 06, 2018

News Scan for Jul 06, 2018

Polio in Afghanistan, Somalia
Pregnancy and flu
CDC reports more Cyclospora illnesses
Frozen veggie Listeria outbreak in Europe

May 10, 2018

May 10, 2018

News Scan for May 10, 2018

Canadian romaine E coli cases
Burkholderia cepacia outbreak
Yellow fever in Brazil
Avian flu outbreaks
Polio emergency continues

Dec 12, 2016

Dec 12, 2016

Flu Scan for Dec 12, 2016

H7N9 cases in China
Avian flu in France, Finland
Generic Tamiflu

Mar 30, 2016

Mar 30, 2016
Neural stem cell

Zika studies explore fetal brain problems, virus damage

A case report finds more fetal evidence of Zika-related brain development problems, and a study on fetal neural cells hints at a possible damage mechanism.

Aug 20, 2014

Aug 20, 2014

News Scan for Aug 20, 2014

Influenza B vaccine mismatch
US chikungunya count rises
Nut butter recall
Seals as ancient TB carriers

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Nov 15, 2012

Nov 15, 2012

FDA panel endorses H5N1 vaccine with adjuvant

(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»